CML-Contributions for the Information Letter

Created by: Hellenbrecht (ELIC Project 2) , generated 2008/04/22 , last changed: 2008/09/23

Table of Content:

Novel collaboration between academia and industry
A novel collaboration between academia and industry to improve treatment in CML
European CML Registry
European Registry of chronic myelogenous leukemia patients in failure after imatinib therapy
Collaboration between Project 4 (CML) and Novartis
The CML Group within the European Leukemia Network agreed on a long term Collaboration with Novartis to improve Understanding ...